Oral recombinant methioninase increases TRAIL receptor-2 expression to regress pancreatic cancer in combination with agonist tigatuzumab in an orthotopic mouse model
Yamamoto, Jun, Miyake, Kentaro, Han, Qinghong, Tan, Yuying, Inubushi, Sachiko, Sugisawa, Norihiko, Higuchi, Takashi, Tashiro, Yoshihiko, Nishino, Hiroto, Homma, Yuki, Matsuyama, Ryusei, Chawla, Sant PJournal:
Cancer Letters
DOI:
10.1016/j.canlet.2020.07.034
Date:
July, 2020
File:
PDF, 11.17 MB
2020